Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation RegistryRoel J.W. van Kampen, Anna Sureda, J.J. Luan et al.|Journal of Clinical Oncology|2011Cited by 216
High-Dose Therapy and Autologous Stem Cell Transplantation in First Relapse for Diffuse Large B Cell Lymphoma in the Rituximab Era: An Analysis Based on Data from the European Blood and Marrow Transplantation RegistryNicolas Mounier, Anna Sureda, Carmen Canals et al.|Transplantation and Cellular Therapy|2011Cited by 118
Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantationCarmen Martı́nez, Anna Sureda, Carmen Canals et al.|Annals of Oncology|2013Cited by 105
Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)Esa Jantunen, Anna Sureda, Michel Attal et al.|Annals of Oncology|2011Cited by 58